Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


GCEC Conference 2014: Entrepreneurship Everywhere

Publication date: Jun 27, 2014 10:57 AM

Start: Oct 02, 2014 12:00 PM
End: Oct 04, 2014 02:00 PM

GCEC Conference 2014 is the premium conference for Centre Directors and stakeholders working within the ever-expanding entrepreneurship ecosystem. This interactive and solutions focused 3 day conference will support Centre Directors and stakeholders in developing their own centres through sharing knowledge, ideas and best practice across the sector and around the globe.

Find out more about the GCEC Conference 2014

GCEC